Background:
We have recently demonstrated that the multi-isoform proinflammatory cytokine IL-32 is upregulated by HIV infection and is associated with subclinical CVD in people living with HIV (PLWH). However, mechanisms by which IL-32 isoforms contribute to the pathogenesis of CVD and potentially other chronic diseases like osteoporosis remain unclear. We investigated the impact of IL-32 isoforms α, β and γ on the differentiation of human mesenchymal stem cells (hMSC) and primary human monocytes into osteoblasts or osteoclasts (cells involved in calcium deposition and bone formation or bone resorption, respectively). These cells are involved in processes that are known to be dysregulated in PLWH in the bone (increased osteoporosis) and in the heart (increased non-calcified, vulnerable atherosclerotic plaque). We hypothesize that alterations in IL-32 isoforms seen in PLWH may be a common cause for bone and heart disease seen in that population.
Methods:
Human CD14+CD16- monocytes or hMSC (osteoblasts precursors) were stimulated with recombinant IL-32 isoforms α, β or γ at 500 ng/ml with or without the osteoclast differentiation factor RANKL (30ng/ml) for 21 days. Immunofluorescence imaging on Spinning-Disc Zeiss AxioObserver was used to identify and analyze the differentiated cells.
Results:
Both IL-32β and IL-32γ but not IL-32α induced the differentiation of hMSC as well as the primary monocytes into osteocalcin+ osteoblast cells. In contrast, IL-32α but not IL-32β or IL-32γ significantly induced the differentiation of a subset of primary CD14+CD16- monocytes into the giant multi-nucleated osteoclasts with the typical expression of the F-actin ring and TRAcP (p<0.0001). Interestingly, when either IL-32β or IL-32γ were combined with RANKL (a typical inducer of osteoclasts), these IL-32 isoforms counteracted the effect of RANKL and maintained their function by inducing osteoblast differentiation from monocytes (p<0.0001 and p=0.0001, respectively), further suggesting their dominant role in osteoblastogenesis.
Conclusions:
Our data reveal a new function for IL-32 isoforms β and γ (the longest IL-32 isoforms) in inducing the differentiation of primary monocytes into osteocalcin+ osteoblasts by counteracting the osteoclast activation factor RANKL. Meanwhile, IL-32α induces the differentiation of osteoclasts. This novel demonstration of the role of IL-32 in regulation of calcium metabolism suggests that it may constitute a common, upstream cause to patterns of bone and heart disease observed in PLWH.